Cargando…

A Case of Combined Hepatocellular-Cholangiocarcinoma with Underlying Schistosomiasis

Combined hepatocellular-cholangiocarcinoma is a rare form of primary liver cancer showing features of both hepatocellular and biliary epithelial differentiation. We report here on a case with collision tumor, which apparently was the coincidental occurrence of both hepatocellular carcinoma and chola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Chang Kyun, Yang, Jin Mo, Kang, Bong Koo, Kim, Jin Dong, Kim, Young Chul, Chang, U-Im, Yoo, Jin Young
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2007
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687661/ https://www.ncbi.nlm.nih.gov/pubmed/18309689 http://dx.doi.org/10.3904/kjim.2007.22.4.283

Ejemplares similares

Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
por: Kim, Jongman, et al.
Publicado: (2023)

A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult
por: Park, Keun Woo, et al.
Publicado: (2015)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma
por: Kim, Gi Jeong, et al.
Publicado: (2013)

Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
por: Park, Hana, et al.
Publicado: (2011)

Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
por: Kim, Sang-Won, et al.
Publicado: (2023)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Update on Pathologic and Radiologic Diagnosis of Combined Hepatocellular-Cholangiocarcinoma
por: Rhee, Hyungjin, et al.
Publicado: (2021)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer
por: Lee, Jung Min, et al.
Publicado: (2022)

CD44 expression in patients with combined hepatocellular cholangiocarcinoma
por: Kim, Ryounggo, et al.
Publicado: (2015)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Current update on combined hepatocellular-cholangiocarcinoma
por: Maximin, Suresh, et al.
Publicado: (2014)

Combined hepatocellular-cholangiocarcinoma in a cow
por: HONDA, Hidetsugu, et al.
Publicado: (2019)

Long‐term outcomes of laparoscopic versus open liver resection for intrahepatic combined hepatocellular‐cholangiocarcinoma with propensity score matching
por: Lee, Seung Jae, et al.
Publicado: (2022)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Cholangiocarcinoma arising in von Meyenburg complexes
por: Kim, Hee Kyung, et al.
Publicado: (2011)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Integrative Evaluation of the Clinical Significance Underlying Protein Arginine Methyltransferases in Hepatocellular Carcinoma
por: Jiang, Yikun, et al.
Publicado: (2023)

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
por: Park, Kyun Woo, et al.
Publicado: (2013)

Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma
por: Park, Sang Eun, et al.
Publicado: (2013)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
por: Kim, Gun Min, et al.
Publicado: (2010)

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
por: Jung, Da Hoon, et al.
Publicado: (2014)

A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
por: Tak, Won Young, et al.
Publicado: (2014)

Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients
por: Kim, Minjae, et al.
Publicado: (2021)

Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma
por: Lee, Sang-Jae, et al.
Publicado: (2014)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma
por: Saboo, Sachin S., et al.
Publicado: (2011)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
por: Roßner, Florian, et al.
Publicado: (2023)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
por: Hou, Gui‐min, et al.
Publicado: (2021)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study
por: Zhao, Qian, et al.
Publicado: (2016)

Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years
por: Kim, Dong Kyun, et al.
Publicado: (2019)

A Case of Fasciola hepatica Infection Mimicking Cholangiocarcinoma and ITS-1 Sequencing of the Worm
por: Kang, Bong Kyun, et al.
Publicado: (2014)

Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma
por: Yang, Xue, et al.
Publicado: (2023)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
por: Zhang, Hai-Chun, et al.
Publicado: (2020)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2vhlaksgv29a4kmm5jh20pk7ik